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Abstract 
Helicobacter pylori infection has been reported to be inversely associated with allergic 
disorders. We by chance experienced a patient with atrophic gastritis who presented 
marked elevations of both nonspecific serum immunoglobulin E and eosinophil counts 
after H. pylori eradication. A 49-year-old Japanese man received eradication of H. pylori 
using lansoprazole 60 mg/day, amoxicillin 1,500 mg/day, and clarithromycin 400 mg/day 
for 7 days. Serum immunoglobulin E increased to more than four times its pretreatment 
level, 306 ] 485 ] 1,325 U/ml, and peripheral eosinophil counts increased to more than 
three times, 99 ] 139 ] 298 per μl. Deducing from the current case, H. pylori eradication 
might develop allergic disorders in some patients. 
 
Introduction 
Recently, Helicobacter pylori (H. pylori) infection has been increasingly reported to be 
inversely associated with allergic diseases [1–3], although some study groups proposed 
discrepancies in the data, i.e. improvement or no improvement in allergic symptoms after 
the eradication [4–6]. We by chance checked nonspecific serum immunoglobulin E (IgE) 
and found a marked rise in its titers following H. pylori eradication therapy.  
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Case Report 
A 49-year-old Japanese man, ex-smoker without allergic disorders, visited Kamifukuoka-Kyodo 
Clinic checking for low serum pepsinogen (PG) levels: PG I 40.8 ng/ml, PG II 15.7 ng/ml, and 
PG I:PG II ratio 2.60, suggesting possible gastric cancer. Gastrofiberscopic examination did not reveal 
gastric cancer, but showed atrophic gastritis with H. pylori infection, i.e. positive results for rapid urease 
test and pathologic findings. The patient wanted to eradicate H. pylori, and a triple drug regimen using 
lansoprazole 60 mg/day, amoxicillin 1,500 mg/day, and clarithromycin 400 mg/day for 7 days was 
initiated in February 2008. He additionally received lansoprazole 30 mg/day for 7 more weeks. 
Following informed consent to check laboratory data on anti-H. pylori antibody titers and 
immunohematologic parameters, complete blood counts, leukocyte differentials, and serum levels of 
immunoglobulin (IgG, IgA, IgM, and IgE) were serially measured. Eight weeks later, a second 
endoscopic examination confirmed successful eradication: negative results for both rapid urease test 
and pathologic findings. At that time, the titer of anti-H. pylori IgG antibody, neutrophil counts, and 
monocyte counts had decreased. On the contrary, peripheral counts of lymphocytes, eosinophils, 
basophils, and platelets had increased (table 1). In addition, serum levels of IgG, IgA, IgM, and IgE had 
all risen. 10 more weeks later, the level of serum IgE increased to four times its pretreatment level: 306 → 
485 → 1,325 U/ml (normal <170). Along with these increases, the number of peripheral eosinophils also 
increased to triple: 99 → 139 → 298 per μl. In addition, we pathologically evaluated IgE-containing cells 
and mast cells in the gastric mucosa (fig. 1, fig. 2). The density of mast cells apparently increased in the 
antrum, although that of IgE-containing cells did not show any difference on the posttreatment 
specimen. The patient neither began to keep animals nor did he receive any additional medications, and 
was free from any signs of allergic disorders by December 2008. 
Discussion 
Infiltration of both neutrophils and lymphocytes into the gastric mucosa is a 
well-known phenomenon among H. pylori-infected patients. In addition, monocytes, 
eosinophils and basophils also have been reported to infiltrate into the gastric mucosa in 
H. pylori-infected persons [7–9]. These observations suggest that H. pylori infection can 
upregulate the peripheral numbers of such leukocytes in infected patients. We therefore 
presume that eradication of H. pylori decreases the numbers of these leukocytes and of 
immunoglobulins in the peripheral blood. Unexpectedly, only neutrophils and monocytes 
decreased with a successful eradication in the patient. Serum IgE and eosinophils were 
continuously increased afterwards. The precise mechanism of this phenomenon is 
unclear, but the following is able to explain the phenomenon: (1) skewed differentiation 
of helper T cell seen in H. pylori-infected patients, (2) hygiene hypothesis, and (3) the 
influence of lansoprazole on serum immunoglobulins. 
H. pylori infection is now accepted to skew T helper differentiation toward type 1 
(Th1) property (production of interleukin-2, interferon-γ, and tumor necrosis factor-α) 
that counteracts the Th2-dependent process [10, 11]. Actually some cell contents of 
H. pylori have been reported to downregulate Th2 inflammation in experimental models 
[12]. As a result of successful eradication, the liberation of Th1 property could enhance 
humoral immunity to upregulate immunoglobulin production, and this regain may 
finally exert upregulation of serum IgE and eosinophilic inflammation induced by the 
Th2-dependent process. 
In recent decades, the decreased prevalence in infectious diseases had led to a rapid 
increase in the prevalence of allergic diseases especially in Western societies, and such 
observation has been explained with the hygiene hypothesis [13]. Exposure to some 
pathogens, including bacteria and viruses, is proven to induce Th1 skew that could be 
preventive for the induction of allergic diseases through counteraction against Th2 cells 
[14, 15].  
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We stained IgE-containing cells and mast cells in the pretreatment and posttreatment 
gastric mucosa. As a result, an increase in mast cell density was observed in the 
posttreatment specimen (fig. 2a, b). Mast cells have been reported to involve gastric 
mucosal damage in patients with gastritis, especially those infected with H. pylori [16]. 
We thus presumed the decreased density of mast cells in the posttreatment specimen, we 
however could not confirm such decrease microscopically. The specimen showed the 
increased density of mast cells after the eradication therapy. Since mast cells involve 
allergic response in humans, this observation may represent H. pylori eradication-induced 
allergy. 
Concerning serum immunoglobulins, we recently reported increases in serum IgG and 
IgM in H. pylori-infected patients treated with lansoprazole, suggesting the altering ability 
on Th1 shift [17]. We however confirmed continuous increases in lymphocytes, 
eosinophils, basophils, IgG and IgE in the peripheral blood at follow-up. Since the patient 
was free from lansoprazole on follow-up, the continuous increases in both IgE and 
eosinophil should be an aftereffect induced by H. pylori eradication.  
This case presentation suggests that some patients are able to develop allergic disorders 
through H. pylori eradication. Since a sole case presentation cannot be applied for an 
exact explanation for the phenomenon, further evaluations using sufficient numbers of 
patients should be performed. 
 
 
 
Table 1. Changes in immunohematologic parameters after eradication 
 Pre  Post  Follow-up 
WBC, /μl  4,310  3,880  4,330 
Neutrophils, /μl  2,853  2,409  2,502 
Lymphocytes, /μl  1,091  1,122  1,209 
Monocytes, /μl  0.228  0.159  0.251 
Eosinophils, /μl  0.099  0.139  0.298 
Basophils, /μl  0.039  00.51  00.70 
Platelets, ×10
4/μl  024.3  024.6  023.6 
α-H. pylori*, U/ml  012.8  011.8  007.4 
IgG, mg/dl  1,100  1,196  1,217 
IgA, mg/dl  0.278  0.282  0.280 
IgM, mg/dl  0.103  0.108  0.105 
IgE**, IU/ml  0.306  0.485 1,325 
* Less than 10.0 are considered to be negative. ** Normal less than 170 IU/ml. 
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Fig. 1. a IgE-containing cells in the antrum of the pretreatment specimen. b IgE-containing cells in the 
antrum of the posttreatment specimen. 
 
 
 
Fig. 2. a Mast cells in the antrum of the pretreatment specimen (toluidine-blue staining). b Mast cells in 
the antrum of the posttreatment specimen (toluidine-blue staining). Arrows indicate stained cells. 
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